Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial

被引:387
作者
Atkin, WS [1 ]
Cook, CF [1 ]
Cuzick, J [1 ]
Edwards, R [1 ]
Northover, JMA [1 ]
Wardle, J [1 ]
机构
[1] St Marks Hosp, Colorectal Canc Unit, Canc Res UK, Harrow HA1 3UJ, Middx, England
基金
英国医学研究理事会;
关键词
D O I
10.1016/s0140-6736(02)08268-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background This randomised controlled trial is examining the hypothesis that a single flexible sigmoidoscopy screening offered at around age 60 years can lower the incidence and mortality of colorectal cancer. We report here on acceptability, safety, feasibility, and yield. Methods Men and women aged 55-64 years, in 14 UK centres, who responded to a mailed questionnaire that they would attend for flexible sigmodoscopy screening if invited, were randomly assigned screening or control (ratio one to two). The control group was not contacted. Small polyps were removed during screening, and colonoscopy was undertaken if high-risk polyps (three or more adenomas, size 1 cm or greater, villous, severely dysplastic, or malignant) were found. Findings Of 354 262 people asked about their interest in having flexible sigmoidoscopy screening, 194 726 (55%) responded positively, and 170 432 eligible individuals were randomised. Attendance among those assigned screening was 71% (40 674 of 57 254). 2131 (5%) were classified as high-risk and referred for colonoscopy; 38 525 with no polyps or only low-risk polyps detected were discharged. Distal adenomas were detected in 4931 (12.1%) and distal cancer in 131 (0.3%). Proximal adenomas were detected in 386 (18.8% of those undergoing colonoscopy) and proximal cancer in nine cases (0.4%). 62% of cancers were Dukes' stage A or locally excised. There was one perforation after flexible sigmoidoscopy and four after colonoscopy. An average of 48 people were screened, and two or three colonoscopy referrals generated, per centre each week. Interpretation Our flexible sigmoidoscopy screening regimen is acceptable, feasible, and safe. The prevalence of neoplasia is high, and colonoscopy referral rates of 5% are acceptable.
引用
收藏
页码:1291 / 1300
页数:10
相关论文
共 35 条
  • [1] Endoscopic perforation of the colon: Lessons from a 10-year study
    Anderson, ML
    Pasha, TM
    Leighton, JA
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (12) : 3418 - 3422
  • [2] Single blind, randomised trial of efficacy and acceptability of oral Picolax versus self administered phosphate enema in bowel preparation for flexible sigmoidoscopy screening
    Atkin, WS
    Hart, A
    Edwards, R
    Cook, CF
    Wardle, J
    McIntyre, P
    Aubrey, R
    Baron, C
    Sutton, S
    Cuzick, J
    Senapati, A
    Northover, JMA
    [J]. BRITISH MEDICAL JOURNAL, 2000, 320 (7248): : 1504 - 1508
  • [3] LONG-TERM RISK OF COLORECTAL-CANCER AFTER EXCISION OF RECTOSIGMOID ADENOMAS
    ATKIN, WS
    MORSON, BC
    CUZICK, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (10) : 658 - 662
  • [4] PREVENTION OF COLORECTAL-CANCER BY ONCE-ONLY SIGMOIDOSCOPY
    ATKIN, WS
    CUZICK, J
    NORTHOVER, JMA
    WHYNES, DK
    [J]. LANCET, 1993, 341 (8847) : 736 - 740
  • [5] Design of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening
    Atkin, WS
    Edwards, R
    Wardle, J
    Northover, JMA
    Sutton, S
    Hart, AR
    Williams, CB
    Cuzick, J
    [J]. JOURNAL OF MEDICAL SCREENING, 2001, 8 (03) : 137 - 144
  • [6] Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening
    Atkin, WS
    Hart, A
    Edwards, R
    McIntyre, P
    Aubrey, R
    Wardle, J
    Sutton, S
    Cuzick, J
    Northover, JMA
    [J]. GUT, 1998, 42 (04) : 560 - 565
  • [7] Calman K, 1994, J Med Screen, V1, P101
  • [8] CANNONALBRIGHT LA, 1994, AM J GASTROENTEROL, V89, P827
  • [9] *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P162
  • [10] Fecal occult blood screening in the Minnesota study: Sensitivity of the screening test
    Church, TR
    Ederer, F
    Mandel, JS
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (19): : 1440 - 1448